TASR also is located about 20 miles down the road, Tab, as I understand it. So, management of TASR has to "look at" Virtra on the way to the office every morning:-)
Wow, right you are. TASR has revenue of 150mil and a market cap of 1.4billion and cash of 67mil and no debt. With a PS pushing 9 they are almost doing a dis-service to their current shareholders if they don't take some sort of action to take advantage of their silly-high stock price. They could buy VirTra now and add 20mil to their top line in 2015 and twice that in 2016. TASR profit margins would remain high and they would have a new growth path in a sister market.
TASR wouldn't even have to dilute current shareholders by issuing more shares. The best deal they (and we) could get would be with cash or maybe mostly cash and a few TASR shares.
TASR market cap and PE is very frothy. They need to buy something to add revs and eps. Virtra would compliment TASR nicely at about .50 pps :-) Happy holidays to all!
A buyout offer in the mid to high .20s before Q1 results, and which will be rejected.
Then again, I've been expecting a buyout for a long time.
2015 predictions??? Buyouts are back in vogue---surely someone is looking at Virtra. I predict bigger quarters and profits and a .50/share price by June. Hits 1.00 on buyout rumors...
Yep, good points all around. One of these days the right investors are going to wake up and start buying. Until then I'd even be happy if some sort of hype machine hedge fund stock pumpin yahoos started driving this up to the stratosphere. Merry Christmas!
NY police commissioner says..."I have received over400 million outside of my normal budget to improve our training, to improve our facilities, to acquire new technology"
Let's hope Virtra salesmen are there....great opportunity
I only mentioned ETRM for your watchlist.
I like the potential for their product but do not
gamble on FDA approvals. I actually sold
most of my shares in ETRM after the run-up its
had in past few weeks. An FDA announcement
is expected before year end. There is plenty of
time to get back on board if the outcome is positive.
I am doing the same with APPY Venaxis.
My success with MDT over the last 40 yrs has
allowed me to search for the next superstar.
I agree with you about evaluating a company like
this? It is sheer speculation. However, If we didn't
have a few wildcats. Life would be pretty dull.
Well, the S&P 500 went up less than 5%. Virtra often has a gap larger than that, and moves more than that from one trade to the next. Any correlation would be lost in the noise.
You're right, I do like "local" companies, especially in the Twin Cities area. That area really has a vibrant economy and many companies understand how to get a really good valuation on their stock.
ETRM - I am clueless about how to evaluate that sort of company, meaning one in development stage without revenue yet. It might turn out to be the greatest thing ever and be a 10 or 20 bagger, I just don't know how to study it or analyze it or weigh risk/reward or likelihood of success. The fact that it is in St. Paul does help because these sort of small start up or developing medical companies have a strong history of success in MN.
Thanks for mentioning it to me. It is one I had never looked at before. I will try to do some more studying and reading and see if I can convince myself to buy some.
I was going to pen this reply on the ETRM message board but was sort of shocked to see all the traffic over there and figured it would be too easy to miss. That alone was a surprise to me and makes me want to dig a bit deeper.
Each year I pick a couple of companies I think will excel
and concentrate on them. HTCH was a favorite this year.
I've been up and down with Hutch so its going to carry over
as one of my favorites for 2015. Turnaround stories don't
happen within the time frame of the impatient.
I know you like Minnesota/Wisc based companies.
Take a look at ETRM. Its also a company I like.
I guess its easy to pay people in shares when you have about 20 million to play with, also at such a low share price. In this case I guess we "got what we paid for" which really didn't seem like much IMHO.